focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.75
Bid: 21.80
Ask: 22.40
Change: -0.10 (-0.46%)
Spread: 0.60 (2.752%)
Open: 21.75
High: 21.75
Low: 21.75
Prev. Close: 21.85
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Jun 2014 07:00

RNS Number : 6353J
Allocate Software PLC
16 June 2014
 



16 June 2014

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

Full Year Trading Update

 

Revenues in line, EBITDA and cash exceed market expectations

 

Allocate Software (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, today provides the following positive update on trading for its financial year ended 31 May 2014. The Company's audited results will be announced on 21 July 2014.

 

Overview

 

Allocate delivered another strong performance with full year revenues in line and EBITDA and cash ahead of market expectations.

 

Healthcare - UK Healthcare bookings exceeded revenue, driven by Allocate Cloud demand

 

The Healthcare business, the Group's main division and primary growth driver, produced another successful year and has continued to perform strongly. During the period, this division secured a significant number of contracts with both new customers and also for new products. Healthcare revenue has risen to 86% of Group revenue from 79% in 2013.

 

UK Healthcare bookings again exceeded revenue, driven principally by the accelerating deployment of the Allocate Cloud, which the Company launched in June 2013.

 

Adoption of Allocate Cloud has exceeded management's expectation with the number of new customers secured in 2014 being significantly higher than that in the prior year. The adoption rate is high due to the reliability, ease of deployment, cost saving and security offered by the service. All Allocate Cloud customers secured in 2013 have either renewed their agreement or are in the process of doing so. This means that over one third of Allocate's NHS HealthRoster customers are now operating on the Allocate Cloud.

 

HealthRoster, Allocate's core application, has maintained its strong growth with the number of new HealthRoster customers secured by the Company consistent with each of the prior two years. The high win rates of previous years have been maintained, as has the previous years' rate of competitive displacements. Additionally, the number of HealthRoster renewals significantly exceeded the number secured in the prior year with renewals continuing at the previously announced 100% rate.

 

The migration to HealthRoster V10 which was launched two years ago continues in line with management's plans. The number of HealthRoster V10 customers that are now live on the platform represents approximately 33% of the HealthRoster installed base, the number contracted and in process is over 50%. HealthRoster V10 adoption is key to sales momentum and the Company now has the platform required to be able to cross-sell new product lines to its installed base of customers.

 

SafeCare All-the-Time, the Company's new suite of applications which have been developed to support the drive within the NHS to improve the transparency of staffing levels, has been well received by customers and prospects. In 2014, some 15% of Allocate's NHS customers contracted for the first product of the new suite to be offered. On 5 June 2014, the full suite was announced and has already generated significant interest from the customer base. SafeCare All-the-Time will be an important growth driver in the next few years.

 

Sales of Allocate's Medics applications have progressed with the total number of new agreements secured slightly short of expectations due to a change in product mix; however these applications did achieve a high renewal rate of annual subscriptions.

 

As stated in the Company's interim results on 20 January 2014, sales of the Patient Flow and Emergency Department product lines have been slower than expected with decision making cycles being longer than originally anticipated. The year has shown strong levels of customer interest, but results have not met expectations.

 

The Company's international Healthcare operations continue to grow and again delivered results that have met management's expectations with both the Nordic and Australian regions achieving year-on-year growth.

 

As the Company enters the new financial year, the UK and Swedish Healthcare pipelines are strong, driven by high levels of customer engagement showing significant interest in our solutions.

 

 

Defence and Maritime- Long-term key customers continue to anchor strong position in sector

 

As stated in the Company's interim results on 20 January 2014, licence revenues from Allocate's defence and maritime divisions are harder to predict and no new customers were secured during the period. Notwithstanding, Allocate continues to maintain a strong position in the Defence and Maritime sector, with long-term key customers in the UK and Australia utilising its solutions and the Group's solution capabilities remain strong. In 2014 the two divisions combined accounted for 14% of Group turnover.

 

 

Ian Bowles, Chief Executive Officer of Allocate commented

 

"2014 was another strong year for Allocate, underpinned by compelling levels of organic revenue growth and a significant increase in profits and margins. We have responded quickly to the evolving requirements of the NHS and during the year have designed, built and deployed the capability to provide the safe staffing reporting required of all NHS Trusts by NHS England and NICE. Our core offering, HealthRoster, has maintained its market leading position. We have secured the same number of new HealthRoster customers as in each of the last two years and continued to renew 100% of HealthRoster term licenses. We more than doubled the number of Cloud customers as well as the number of customers that are now live on the V10 platform.

 

 

"Allocate closes the financial year 2014 with high levels of customer engagement and we remain confident that we are well positioned to continue to meet their needs and deliver on the strategy that we have laid out."

 

 

Allocate Software

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

 

 

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis / Richard Thomas

Corporate Broking - James Black

 

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Matt Dixon / Chris Lane

Tel: +44 (0) 20 3727 1000

 

About Allocate Software plc

Allocate Software plc is the leading workforce optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

 

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA and Australia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUOOVRSRANAAR
Date   Source Headline
15th Jul 20085:43 pmRNSHolding(s) in Company
30th Jun 20087:00 amRNSDirectorate Change
10th Jun 20087:00 amRNSAward of Contract
2nd Jun 20087:00 amRNSAward of Contracts
27th May 20089:34 amRNSDirector/PDMR Shareholding
22nd May 20087:00 amRNSAward of Contract
6th May 20087:02 amRNSAward of Directors' Options
2nd May 20087:00 amRNSHolding(s) in Company
7th Apr 20087:01 amRNSAcquisition
4th Apr 20087:01 amRNSTrading Statement
26th Mar 20088:00 amRNSAward of Contract
17th Mar 20087:00 amRNSAward of Contract
10th Mar 20087:00 amRNSAward of Contract
4th Mar 20087:00 amRNSAward of Contract
28th Feb 20089:01 amRNSExercise of Share Options
26th Feb 20087:00 amRNSAward of Contract
21st Feb 20087:00 amRNSAward of Contract
6th Feb 20087:01 amRNSInterim Results
4th Feb 20087:01 amRNSAward of Contract
31st Jan 20087:00 amRNSAward of Contract
22nd Jan 20087:00 amRNSAward of Contract
18th Jan 20087:01 amRNSAward of Contract
17th Jan 20087:00 amRNSHolding(s) in Company
15th Jan 200812:06 pmRNSHolding(s) in Company
4th Jan 20089:38 amRNSTotal Voting Rights
4th Jan 20087:00 amRNSAward of Contract
4th Jan 20087:00 amRNSAward of Contract
3rd Jan 20088:46 amRNSAward of Contract
20th Dec 20077:01 amRNSAGM Statement
12th Dec 200711:13 amRNSHolding(s) in Company
11th Dec 20077:00 amRNSCorrection: Holdings in Co.
10th Dec 20074:43 pmRNSHolding(s) in Company
3rd Dec 200711:30 amRNSDirector/PDMR Shareholding
29th Nov 20077:01 amRNSCirc re. contract extension
21st Nov 20077:01 amRNSDirector/PDMR Shareholding
20th Nov 20077:01 amRNSChange of Adviser
8th Nov 200710:08 amRNSHolding(s) in Company
7th Nov 20071:34 pmRNSAward of Contract
5th Nov 20073:00 pmRNSDirector/PDMR Shareholding
18th Oct 200712:08 pmRNSRe Contract
27th Sep 20075:18 pmRNSHolding(s) in Company
27th Sep 20073:30 pmRNSAward of contract
20th Sep 20073:15 pmRNSAward of Contract
19th Sep 200711:31 amRNSHolding(s) in Company
19th Sep 20079:02 amRNSDirector/PDMR Shareholding
5th Sep 200710:25 amRNSHolding(s) in Company
23rd Aug 20071:47 pmRNSAward of Contract
17th Aug 200711:59 amRNSHolding(s) in Company
6th Aug 20071:00 pmRNSAward of Contract
31st Jul 20077:01 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.